Woodline Partners LP - 31 Dec 2025 SCHEDULE 13G/A Report for Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)

Filing Manager: Woodline Partners LP
Reporting Manager: Woodline Partners LP
Security: Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol: ALGS
Shares outstanding: 5,354,981 shares
Disclosed Ownership: 289,169 shares
Ownership: 5.4%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 15:22:03 UTC
Date of event: 31 Dec 2025
Previous filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Woodline Partners LP	5.4%	289,169	289,169	0	/s/ Erin Mullen	Erin Mullen, General Counsel & Chief Compliance Officer